OVARIAN CANCER

Ovarian cancer early detection, early treatment, the greater the chance of cure. But ovarian cancer early detection more difficult. Usually, women with ovarian cancer no symptoms or mild discomfort, only to the late period before a noticeable symptoms. Scientists are studying the symptoms, identify methods of ovarian cancer. They found blood in the CA-125, a tumor marker in women with ovarian cancer was significantly increased; Ultrasound can also help early detection of diseases.
The census is a large-scale tumors, including prostate, lung, colorectal and ovarian cancer, the evaluation of tumor markers in the blood of the level of CA-125 and transvaginal ultrasound examination in the early diagnosis of ovarian cancer value.

Tags: abdominal, age, bleeding, blood, body, cancer, care, cause, cyst, cysts, diagnosis, early, eat, examination, history, increased, mass, method, ovarian, ovary, pain, patients, pelvic, physical, poor, powder, resection, staging, study, surgery, surgical, symptoms, treatment, tumor, tumors, usually, women

Ovarian cancer

Tags: abdominal, age, benign, bleeding, blood, body, cancer, cause, cell, cells, clinical, cyst, examination, fat, growth, head, malignant, mass, ovarian, pain, second, symptoms, tumor, tumors, women

Patients with malignant ovarian tumor when treatment is late (> Phase II), ovarian cancer is the surgical treatment called tumor or cytoreductive surgery or large resection.
Surgery is to do everything possible to the original tumor resection and can see the pots, peritoneal metastasis, so that each region of residual lesion diameter of less than 2.0 cm to 1.5 cm. Intraoperative from ascites fluid or cells for blood screening. Because ovarian and uterine cancer often, the annex or visco-invasion, peritoneal and keep pots, it is more of "carpet-volume" or "dumplings", from extraperitoneal space elements from the peritoneal wall, bladder and pelvic floor serous peritoneal, along with the uterus and pelvic peritoneum block tumor resection. The pots have peritoneal metastasis tissues or organs should be possible to complete resection or partial resection, resection of the omentum, some intestinal resection, resection of the bladder or ureter shifting values. The removal of the tumor as possible aim is to enhance postoperative radiotherapy and chemotherapy effect. The merger of ovarian cancer ascites, regardless of whether all resection are advised to intraperitoneal indwelling catheter for intraperitoneal injection of anti-cancer drugs. Anti-cancer drugs or radioisotopes for preparation also can be injected directly unresectable tumors.
Surgery can not decide in its benign and malignant ovarian tumor resection specimens should be admitted or contralateral ovarian tissue frozen tablets sent for histopathologic examination. There is no such conditions, generally after the contralateral normal ovarian As can be temporarily retained, pathological specimens were sent checks to clear in nature, and close observation. The previous suspected metastatic ovarian tumor and failed to find its source, should be in operation in detail in the original exploration of abdominal lesions, after further treatment for reference.

Tags: abdominal, annex, anti, benign, blood, cancer, cause, cell, cells, chemotherapy, drug, drugs, eat, examination, exploration, gene, injection, intraperitoneal, malignant, metastasis, metastatic, ovarian, patients, pelvic, radiotherapy, resection, residual, screening, surgery, surgical, therapy, treatment, tumor, tumors, uterine

Ovarian cancer

Tags: age, annex, blood, body, cancer, cases, cell, cells, chemotherapy, clinical, cyst, cystic, diagnosis, drug, drugs, early, eat, examination, fat, mass, method, ovarian, pain, patients, pelvic, poor, prognosis, reduce, resection, study, surgical, symptoms, therapy, time, toxicity, treatment, tumor, tumors, women

You are interested in the manual open to learning the prevention and treatment of ovarian cancer, you may answer the following questions, which are from the United States, 199 by the latest knowledge of ovarian cancer questionnaire. Facts have proved that the developed countries in Europe and the United States these people are aware of ovarian cancer rarely. Gynecologic Oncology experts say: lack of knowledge of ovarian cancer is the cause of ovarian cancer mortality leapt to the forefront of gynecologic cancer mortality one of the major reasons. How do you these basic knowledge of the number of ovarian cancer?

Tags: abdominal, age, blood, body, breast, cancer, cause, cell, diagnosis, early, eat, ert, examination, family, gene, growth, gynecological, history, incidence, knowledge, life, lymph, metastasis, method, node, ovarian, ovary, pain, patients, pelvic, rate, reduce, risk, screening, survival, symptoms, time, treatment, tumor, tumors, women, wrong

Basic symptoms: early ovarian cancer usually no obvious symptoms, if there is non-specific symptoms, such as menstrual disorder, mild gastrointestinal discomfort. With the growth of tumors may arise under bloating, discomfort, or sometimes because of oppression involved in the bladder or rectum and frequency, diarrhea, constipation,. More advanced symptoms from ascites, omental or metastatic gastrointestinal such as abdominal distension, shortness of breath, abdominal discomfort, and incomplete intestinal obstruction or even obstructive symptoms. Part of mesenchymal tumors or tumor invasion of genistein and uterus can cause irregular vaginal bleeding. If a tumor metastasis may have different performance of the corresponding organ involvement.

Tags: abdominal, age, bleeding, blood, cancer, cause, cell, chemotherapy, cyst, cystic, diagnosis, early, eat, ert, examination, gene, grams, growth, gynecological, injection, knowledge, malignant, mass, metastasis, metastatic, oppression, ovarian, patients, pelvic, prognosis, radiotherapy, residual, screening, staging, surgery, symptoms, therapy, time, treatment, tumor, tumors, usually

1). Transfer of malignant ovarian tumor growth and metastasis, and other parts of the same direct spread of cancer, and the lymphatic and blood way. But the transfer spread mainly by direct more directly transferred to pots, abdominal organs and organizations, or transfer of Tai omentum, mesenteric, in a number of intraperitoneal nodular mass, a certain degree of mobility; Peritoneal or transferred to the pelvic floor in the vaginal fornix after palpation, palpable in the womb may have rectal Waterloo a papillary protrusions, even penetrating pelvic viscera, a sinus, and the rectum,; a vaginal or urethral cancer tissue from the pus and bleeding. Ovarian cancer found in the lymph node metastasis rate as high as 50%, or even transferred to the left supraclavicular lymph nodes, or perineum, is in the diagnosis and treatment of ovarian cancer, attention.

Tags: abdominal, bleeding, blood, cancer, cases, cause, clinical, diagnosis, eat, ert, growth, intraperitoneal, lymph, malignant, mass, metastasis, node, oppression, ovarian, pelvic, rate, symptoms, treatment, tumor, tumors

Amenorrhea is common clinical symptoms, their causes are complex, the causes can be divided into the central nervous system and the hypothalamus, pituitary, ovary and uterus of amenorrhea, including congenital Gonadal Dysgenesis and autoimmune ovarian inflammation. As such closure gonadotropin levels often associated with higher estrogen levels decrease, it said hypergonadotropic amenorrhea, gonadotropin levels higher than normal cycle or reached menopause, clinical manifestations of primary or secondary amenorrhea.

Tags: age, amenorrhea, anti, blood, body, cause, clinical, diagnosis, eat, ert, estrogen, examination, gene, ovarian, ovary, patients, pelvic, poor, positive, rate, second, symptoms, time, treatment

One, paclitaxel and cisplatin in the treatment of advanced ovarian cancer care <BR> <BR> 1990s Taxol is more of the treatment of advanced ovarian cancer drug effective, and its unique mechanism is a new type of anti-tubulin role of antitumor drugs. Cisplatin for inorganic platinum metal complex, the cell cycle-specific drug, can inhibit DNA synthesis, combined with their synergies to enhance the effectiveness of [1]. In Division I from July 1996 to July 1998 to 15 cases of advanced ovarian cancer patients with Taxol and cisplatin in the treatment of satisfactory results.

One, information and Methods

Tags: administration, age, anti, blood, body, cancer, care, cases, cause, cell, cells, chemotherapy, cisplatin, clinical, confidence, days, diet, dose, drug, drugs, eat, ert, estrogen, family, fat, gene, group, growth, incidence, infusion, injection, intravenous, life, mass, metastasis, method, ovarian, paclitaxel, pain, patients, physical, poor, positive, psychological, quality, rate, reduce, response, skin, surface, surgery, survival, symptoms, taxol, therapy, time, toxicity, treatment, tumor, tumors, women

Austria adopted interferon combination of chemotherapy and women's ovarian cancer treatment, and achieved better than chemotherapy alone effect.

Austrian University of Innsbruck gynecological experts led by Professor Christian Anmaerte a Gynecologic Oncology Group study started three years ago one of the study. Their 148 already one ovarian cancer surgery in women with a combination of chemotherapy for the treatment of interferon test. Six patients received treatment three times a week in treatment, and the other a comparison group of patients is only chemotherapy. Results of 51% in patients treated with interferon did not recur tumor, and comparison group only 38% of patients with tumors did not recur.

Tags: blood, body, cancer, cell, cells, chemotherapy, eat, ert, group, growth, gynecological, interferon, ovarian, patients, protein, study, surgery, therapy, time, treatment, tumor, tumors, women